EXT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.562000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.318400E-01
Normal-vs-Stage2
8.001200E-01
Normal-vs-Stage3
6.532800E-01
Normal-vs-Stage4
5.024800E-01
Stage1-vs-Stage2
1.839560E-01
Stage1-vs-Stage3
8.993000E-01
Stage1-vs-Stage4
8.231800E-02
Stage2-vs-Stage3
3.295200E-01
Stage2-vs-Stage4
3.551600E-01
Stage3-vs-Stage4
2.326000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.849800E-01
Normal-vs-AfricanAmerican
5.575800E-01
Normal-vs-Asian
7.700000E-01
Caucasian-vs-AfricanAmerican
4.630800E-01
Caucasian-vs-Asian
4.530400E-01
AfricanAmerican-vs-Asian
1.640200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.753800E-01
Normal-vs-Female
8.158200E-01
Male-vs-Female
9.560800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.200000E-01
Normal-vs-Age(41-60Yrs)
4.093200E-01
Normal-vs-Age(61-80Yrs)
9.183800E-01
Normal-vs-Age(81-100Yrs)
6.820400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.400850E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.219200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.351600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.785800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.355700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.756400E-01
Normal-vs-Daily Drinker
7.613200E-01
Normal-vs-Weekly Drinker
8.833600E-01
Normal-vs-Occasional Drinker
5.136600E-01
Normal-vs-Social Drinker
7.255600E-01
Non Drinker-vs-Daily Drinker
6.272200E-01
Non Drinker-vs-Weekly Drinker
1.771590E-01
Non Drinker-vs-Occasional Drinker
3.439800E-02
Non Drinker-vs-Social Drinker
6.870200E-02
Daily Drinker-vs-Weekly Drinker
3.959200E-01
Daily Drinker-vs-Occasional Drinker
6.483900E-02
Daily Drinker-vs-Social Drinker
2.010000E-01
Weekly Drinker-vs-Occasional Drinker
2.163400E-01
Weekly Drinker-vs-Social Drinker
7.029000E-01
Occasional Drinker-vs-Social Drinker
3.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.774000E-01
Normal-vs-Grade 2
2.207800E-01
Normal-vs-Grade 3
2.085600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.840400E-03
Grade 1-vs-Grade 3
4.463200E-03
Grade 1-vs-Grade 4
8.774000E-01
Grade 2-vs-Grade 3
7.940200E-01
Grade 2-vs-Grade 4
2.207800E-01
Grade 3-vs-Grade 4
2.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.464600E-01
Normal-vs-NonDiabetic
8.441800E-01
Diabetic-vs-NonDiabetic
4.037800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.842800E-01
Normal-vs-NoPancreatitis
9.091800E-01
Pancreatitis-vs-NoPancreatitis
5.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.591200E-01
Normal-vs-N1
7.721200E-01
N0-vs-N1
2.264600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.257400E-01
Normal-vs-TP53-NonMutant
7.039400E-01
TP53-Mutant-vs-TP53-NonMutant
6.428800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
